1. Home
  2. SLN vs COOK Comparison

SLN vs COOK Comparison

Compare SLN & COOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLN
  • COOK
  • Stock Information
  • Founded
  • SLN 1994
  • COOK 1985
  • Country
  • SLN United Kingdom
  • COOK United States
  • Employees
  • SLN N/A
  • COOK N/A
  • Industry
  • SLN Biotechnology: Pharmaceutical Preparations
  • COOK Wholesale Distributors
  • Sector
  • SLN Health Care
  • COOK Consumer Discretionary
  • Exchange
  • SLN Nasdaq
  • COOK Nasdaq
  • Market Cap
  • SLN 352.2M
  • COOK 406.5M
  • IPO Year
  • SLN N/A
  • COOK 2021
  • Fundamental
  • Price
  • SLN $6.41
  • COOK $2.99
  • Analyst Decision
  • SLN Strong Buy
  • COOK Buy
  • Analyst Count
  • SLN 4
  • COOK 6
  • Target Price
  • SLN $61.50
  • COOK $4.00
  • AVG Volume (30 Days)
  • SLN 959.2K
  • COOK 164.1K
  • Earning Date
  • SLN 11-14-2024
  • COOK 11-06-2024
  • Dividend Yield
  • SLN N/A
  • COOK N/A
  • EPS Growth
  • SLN N/A
  • COOK N/A
  • EPS
  • SLN N/A
  • COOK N/A
  • Revenue
  • SLN $21,773,221.00
  • COOK $598,914,000.00
  • Revenue This Year
  • SLN N/A
  • COOK $1.02
  • Revenue Next Year
  • SLN $104.98
  • COOK $4.69
  • P/E Ratio
  • SLN N/A
  • COOK N/A
  • Revenue Growth
  • SLN N/A
  • COOK 3.17
  • 52 Week Low
  • SLN $5.81
  • COOK $1.97
  • 52 Week High
  • SLN $27.72
  • COOK $3.97
  • Technical
  • Relative Strength Index (RSI)
  • SLN 27.24
  • COOK 41.52
  • Support Level
  • SLN $6.06
  • COOK $2.94
  • Resistance Level
  • SLN $8.88
  • COOK $3.31
  • Average True Range (ATR)
  • SLN 0.72
  • COOK 0.14
  • MACD
  • SLN 0.22
  • COOK -0.02
  • Stochastic Oscillator
  • SLN 22.52
  • COOK 8.16

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.

About COOK Traeger Inc.

Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.

Share on Social Networks: